Tempus AI signed an agreement with the University of Southern California to deploy molecular diagnostics and comprehensive genomic profiling for clinical precision medicine use across USC’s Keck School of Medicine and Keck Medicine hospital system. The collaboration also includes access to Tempus’ Time Trial clinical trial matching and AI tools, according to the company. The alliance pairs Tempus platform capabilities with USC’s clinical and research infrastructure and includes work on new diagnostics, therapies, and AI development. Financial terms were not disclosed. The partnership adds to Tempus’ network-building in oncology diagnostics and suggests further integration of genomic profiling with trial matching systems inside academic medical centers.